Non stimulant adhd drugs
Pro Research Analysisby 
Searched over 200M research papers
Non-Stimulant ADHD Drugs: An Overview
Introduction to Non-Stimulant ADHD Medications
Attention-Deficit/Hyperactivity Disorder (ADHD) is commonly treated with stimulant medications like methylphenidate and amphetamines. However, not all patients respond well to stimulants, and some experience adverse effects. This has led to the exploration of non-stimulant medications as alternative treatments for ADHD1 4.
Types of Non-Stimulant ADHD Medications
Atomoxetine
Atomoxetine is a selective norepinephrine reuptake inhibitor and is one of the most well-studied non-stimulant medications for ADHD. It has been shown to be effective across the lifespan and is generally well-tolerated, with side effects being mild and transient4 6. Atomoxetine is often recommended as a second-line treatment when stimulants are not suitable9.
Alpha-2 Adrenergic Agonists
Medications like clonidine and guanfacine fall under this category. These drugs are particularly useful in patients with comorbid conditions such as tics or anxiety. While the evidence supporting their efficacy is not as robust as for stimulants, they are considered a viable option for specific patient subgroups4 9.
Tricyclic Antidepressants (TCAs)
TCAs such as desipramine and imipramine have been documented to be effective in treating ADHD. However, their use is limited by side effects, which can be more severe compared to other non-stimulant options4 9.
Other Novel Compounds
Recent research has explored various novel compounds, including dasotraline, viloxazine, and centanafadine. These medications act on different biological targets and offer potential benefits in terms of tolerability and efficacy1. However, more research is needed to fully understand their long-term effects and safety profiles.
Efficacy and Safety of Non-Stimulant Medications
Efficacy
Non-stimulant medications generally have a lower effect size compared to stimulants. However, they can be effective for patients who do not respond to or cannot tolerate stimulants. Atomoxetine, for instance, has shown significant efficacy in reducing ADHD symptoms, although it may take longer to see clinical effects compared to stimulants4 5.
Safety
Non-stimulant medications are generally well-tolerated. Common side effects include decreased appetite, growth suppression, and sleep disturbances. Cardiovascular effects are also a concern, particularly with atomoxetine, which has been associated with small but statistically significant increases in blood pressure and heart rate2 6. Regular monitoring is recommended to manage these potential risks.
Conclusion
Non-stimulant medications offer a valuable alternative for the treatment of ADHD, particularly for patients who do not respond well to stimulants or experience significant side effects. Atomoxetine, alpha-2 adrenergic agonists, and TCAs are among the most commonly used non-stimulant options, each with its own set of benefits and limitations. Ongoing research into novel compounds continues to expand the range of available treatments, moving towards a more personalized approach to ADHD management.
Sources and full results
Most relevant research papers on this topic
Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD
Novel non-stimulant ADHD medications may offer comparable or better tolerability than stimulants, advancing precision medicine in ADHD treatment.
Systematic ReviewCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
ADHD medications methylphenidate, amphetamines, and atomoxetine may have small but significant cardiovascular effects in children and adolescents, with a small to medium increase in heart rate.
Meta-Analysis
Rigorous Journal
Highly CitedThe pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
Behavioral therapy, stimulants, and their combination are the most effective and well-tolerated treatments for ADHD in children and adolescents.
Meta-AnalysisRigorous JournalHighly CitedNon–stimulant medications in the treatment of ADHD
Non-stimulant agents, particularly atomoxetine, show promise in treating ADHD, with new drugs in development.
Literature ReviewHighly CitedThe use of non-stimulant drugs in the treatment of adult ADHD
Non-stimulant drugs for adult ADHD show limited effectiveness due to their inferior effectsize, daily dosing, and delayed onset compared to stimulants.
Systematic ReviewPediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD
ADHD medications in children and adolescents are generally safe and well-tolerated, with common adverse events including decreased appetite, growth decrease, and sleep disturbances.
Systematic ReviewStimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
Stimulant and non-stimulant drugs can both reduce seizure frequency and severity in children and adults with ADHD and comorbid epilepsy, but their effects on ADHD symptoms, adverse effects, and Quality of Life need further research.
Systematic Review
Very Rigorous JournalA Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD)
Stimulant optimization is crucial for managing stimulant-refractory ADHD, and alternative pharmacological strategies should be considered for patients with poor adherence, time action properties, tolerability, and comorbid non-ADHD symptoms.
Systematic ReviewVery Rigorous JournalThe safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder
Non-stimulant treatments for ADHD are generally well-tolerated with moderate side effects, but specific safety aspects and precautions must be considered for each drug.
Non-stimulant treatments for ADHD
Non-stimulant treatments like tricyclic antidepressants, atypical antidepressants, and tomoxetine show promise in treating ADHD, while more research is needed on alternative pharmacologic treatments.
Literature ReviewRigorous Journal